Global Thrombosis Test – a possible monitoring system for the effects and safety of dabigatran

BACKGROUND: Dabigatran is an alternative to warfarin (WF) for the thromboprophylaxis of stroke in patients with non-valvular atrial fibrillation (NVAF). The advantage of dabigatran over WF is that monitoring is not required; however, a method to monitor the effect and the safety of dabigatran is not...

Descripción completa

Detalles Bibliográficos
Autores principales: Otsui, Kazunori, Gorog, Diana A., Yamamoto, Junichiro, Yoshioka, Takayuki, Iwata, Sachiyo, Suzuki, Atsushi, Ozawa, Toru, Takei, Asumi, Inoue, Nobutaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Original Clinical Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4672538/
https://www.ncbi.nlm.nih.gov/pubmed/26648789
http://dx.doi.org/10.1186/s12959-015-0069-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4672538/
https://www.ncbi.nlm.nih.gov/pubmed/26648789
http://dx.doi.org/10.1186/s12959-015-0069-6

Ejemplares similares